Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 11/20 | 0.57 |
| ▸ | FAAH | O00519 | 10/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | SPR | P35270 | 1/20 | 0.36 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.35 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25488049 | 0.92 | MGLL (0.67) | MGLLFAAH | |
| SCHEMBL25830293 | 0.91 | FAAH (0.58) | MGLLFAAHDRD4TMEM97SIGMAR1 | |
| SCHEMBL25830203 | 0.87 | MGLL (0.64) | MGLLFAAH | |
| SCHEMBL25830117 | 0.86 | MGLL (0.58) | MGLLFAAH | |
| SCHEMBL25830201 | 0.84 | FAAH (0.72) | MGLLFAAH | |
| SCHEMBL25488092 | 0.83 | FAAH (0.68) | MGLLFAAH | |
| SCHEMBL25830291 | 0.83 | FAAH (0.68) | MGLLFAAH | |
| SCHEMBL25830205 | 0.82 | MGLL (0.60) | MGLLFAAH | |
| SCHEMBL20567912 | 0.81 | MGLL (0.71) | MGLLFAAH | |
| SCHEMBL25830386 | 0.81 | FAAH (0.53) | MGLLFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | MGLL, PNLIP, LPL | MGLL 1/4885FAAH 33/4885DRD4 4707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.